Bahrain vs IDA blend: Cause of death, by non-communicable diseases, female
Bahrain
80.4%
in 2021
IDA blend
44.6%
in 2021
Bahrain rank
38th
IDA blend rank
39th
Cause of death, by non-communicable diseases, female over time
- Bahrain
- IDA blend
How they compare
Bahrain currently reports 80.4% against 44.6% in IDA blend, a difference of 35.8%.
That makes Bahrain's figure about 1.8 times IDA blend's.
Across all 6 years both countries report, Bahrain has been ahead every year.
Bahrain ranks 38th and IDA blend ranks 39th of 185 countries.
Bahrain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | IDA blend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.5% | 29.1% | 57.4% | Bahrain |
| 2010s | 91.2% | 41.0% | 50.2% | Bahrain |
| 2020s | 81.9% | 44.6% | 37.4% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Bahrain or IDA blend?
- Bahrain, at 80.4% against 44.6% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Bahrain and IDA blend?
- 35.8%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and IDA blend?
- 6 years are reported by both, from 2000 to 2021.
- How do Bahrain and IDA blend rank globally for cause of death, by non-communicable diseases, female?
- Bahrain ranks 38th and IDA blend ranks 39th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.